nGL 12.5 (Movantik 12.5 mg)
Generic Name: naloxegol
Pill with imprint nGL 12.5 is Purple, Elliptical / Oval and has been identified as Movantik 12.5 mg. It is supplied by AstraZeneca Pharmaceuticals LP.
Movantik is used in the treatment of opioid-induced constipation; constipation, chronic; constipation, drug induced and belongs to the drug class peripheral opioid receptor antagonists. Risk cannot be ruled out during pregnancy. Movantik 12.5 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for nGL 12.5
Movantik
- Generic Name:
- naloxegol
- Imprint:
- nGL 12.5
- Strength:
- 12.5 mg
- Color:
- Purple
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Drug Class:
- Peripheral opioid receptor antagonists
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- AstraZeneca Pharmaceuticals LP
- National Drug Code (NDC):
- 00310-1969
More about Movantik (naloxegol)
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- En Español
- 162 Reviews – Add your own review/rating
- Drug class: peripheral opioid receptor antagonists
Consumer resources
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
